noiiglutide (SHR20004) / Jiangsu Hengrui Pharma, Jiangsu Hansoh Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
noiiglutide (SHR20004) / Jiangsu Hengrui Pharma
NCT03848793: A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.

Completed
2
128
RoW
HS-20004, Noiiglutide Injection
Jiangsu HengRui Medicine Co., Ltd.
Diabetes Mellitus, Type 2
06/20
12/20
NCT04799327: The Effect of SHR20004（Noiiglutide ） on Body Weight in Obese Subjects Without Diabetes

Active, not recruiting
2
254
RoW
SHR20004, placebo
Jiangsu HengRui Medicine Co., Ltd.
Obesity
05/22
05/22
NCT05333835: A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes

Active, not recruiting
2
455
RoW
HR17031 injection, INS068 injection, SHR20004 injection
Jiangsu HengRui Medicine Co., Ltd.
Type 2 Diabetes
03/24
03/24

Download Options